Regulatory 2020-05-06 | First participant enrolled in the clinical hepatic impairment study with Mangoral PDF Report Presentation Webcast
2020-03-05 | Analysguiden/Carlsquare updates its view on Ascelia Pharma and raises target share price PDF Report Presentation Webcast
2020-02-20 | Vator Securities: Ascelia Pharma: A rocket roll out is the key to success PDF Report Presentation Webcast
Regulatory 2020-02-19 | First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral PDF Report Presentation Webcast
2020-02-11 | Ascelia Pharma wins the award for Best Life Science company in Malmö PDF Report Presentation Webcast
2020-01-13 | Five sites now opened in the pivotal Phase III clinical study SPARKLE for lead drug candidate Mangoral PDF Report Presentation Webcast
2019-11-08 | Preparations for Phase III study with Mangoral[®] on track PDF Report Presentation Webcast
Regulatory 2019-06-10 | Ascelia Pharma strengthens its Mangoral franchise by filing of a patent application for next generation Mangoral product PDF Report Presentation Webcast
2019-05-15 | Fully financed Phase III program for Mangoral through the IPO PDF Report Presentation Webcast
Regulatory 2019-05-07 | Ascelia Pharma received supportive feedback from EMA on the phase 3 program for Mangoral® PDF Report Presentation Webcast
Regulatory 2019-04-08 | Encouraging results from the Phase I combination study with Oncoral and oral capecitabine published in the journal Cancer Chemotherapy and Pharmacology PDF Report Presentation Webcast
2018-11-19 | Ascelia Pharma receives positive feedback from FDA on design of the pivotal Phase 3 study with Mangoral® PDF Report Presentation Webcast
2018-11-13 | Encouraging results from clinical Phase I study of Oncoral presented in a new publication PDF Report Presentation Webcast
2018-10-23 | Oncoral demonstrates encouraging results in clinical phase I PDF Report Presentation Webcast
2018-09-10 | Oncoral phase 1 results to be presented at ESMO congress in Munich PDF Report Presentation Webcast
2017-09-14 | Ascelia Pharma strengthens its oncology product portfolio PDF Report Presentation Webcast
